Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yu Ri Nam"'
Publikováno v:
ACS Omega, Vol 9, Iss 2, Pp 2953-2961 (2023)
Externí odkaz:
https://doaj.org/article/a5f1ce8119154ed09aeb20e6d101d59f
Autor:
Jeong Pil Han, Yeji Lee, Jeong Hyeon Lee, Hye Yoon Chung, Geon Seong Lee, Yu Ri Nam, Myeongjin Choi, Kyoung-Sik Moon, Haeshin Lee, Hyukjin Lee, Su Cheong Yeom
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 34, Iss , Pp 102050- (2023)
Gene therapy and rebalancing therapy have emerged as promising approaches for treating hemophilia A, but there are limitations, such as temporary efficacy due to individual differences. Genome editing for hemophilia has shown long-term therapeutic po
Externí odkaz:
https://doaj.org/article/04122e44a72248089f84d8113f0cc24e
Autor:
Marcel Janis Beha, Joo‐Chan Kim, San Hae Im, Yunsu Kim, Seungju Yang, Juhee Lee, Yu Ri Nam, Haeshin Lee, Hee‐Sung Park, Hyun Jung Chung
Publikováno v:
Advanced Science, Vol 10, Iss 27, Pp n/a-n/a (2023)
Abstract Bioconjugation of proteins can substantially expand the opportunities in biopharmaceutical development, however, applications are limited for the gene editing machinery despite its tremendous therapeutic potential. Here, a self‐delivered n
Externí odkaz:
https://doaj.org/article/0d714f4750664c6d9f6df4cc5cbf0bbc
Publikováno v:
Micromachines, Vol 12, Iss 10, p 1147 (2021)
Cancer is a dynamic disease involving constant changes. With these changes, cancer cells become heterogeneous, resulting in varying sensitivity to chemotherapy. The heterogeneity of cancer cells plays a key role in chemotherapy resistance and cancer
Externí odkaz:
https://doaj.org/article/bf8c01ac8a2f4c1caeeda8d8183d2ae9
Autor:
Dong Eun Kim, Jinho Lee, Jong Wook Park, Hyunsu Kang, Yu Ri Nam, Taeg Kyu Kwon, Ki-Suk Kim, Shin Kim
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 8, p 4268 (2021)
Previous studies have investigated the inhibitory effect of BMI-1026 on cyclin-dependent kinase 1 in vitro. However, the molecular mechanisms by which BMI-1026 treatment leads to cancer cell death remain unclear. This study was conducted to investiga
Externí odkaz:
https://doaj.org/article/fe98c43a6bb74f8089d4644080e70b4c
Autor:
Yu Ri Nam, Helen H. Ju, Jeehee Lee, Daiheon Lee, Yoojin Kim, Sung Jin Lee, Hong Kee Kim, Jae-Hyung Jang, Haeshin Lee
Publikováno v:
Langmuir. 39:6740-6747
Autor:
Shin Kim, Hyunsu Kang, Taeg Kyu Kwon, Yu Ri Nam, Dong-Eun Kim, Jong-Wook Park, Jinho Lee, Ki-Suk Kim
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 4268, p 4268 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 8
International Journal of Molecular Sciences
Volume 22
Issue 8
Previous studies have investigated the inhibitory effect of BMI-1026 on cyclin-dependent kinase 1 in vitro. However, the molecular mechanisms by which BMI-1026 treatment leads to cancer cell death remain unclear. This study was conducted to investiga
Publikováno v:
Micromachines
Volume 12
Issue 10
Micromachines, Vol 12, Iss 1147, p 1147 (2021)
Volume 12
Issue 10
Micromachines, Vol 12, Iss 1147, p 1147 (2021)
Cancer is a dynamic disease involving constant changes. With these changes, cancer cells become heterogeneous, resulting in varying sensitivity to chemotherapy. The heterogeneity of cancer cells plays a key role in chemotherapy resistance and cancer